In RCC-derived stem-like cell lines, CD146 levels are elevated a substantial fraction of the cell population and, since most of the cells are EpCAM positive, it is likely that both markers are co-expressed (Additional file 2: Figure S1E). This evidence concerns the gene EPCAM and renal cell adenocarcinoma.